Effects of prostaglandin E1 on cultured dermal fibroblasts from normal and hypertrophic scarred skin

Journal of Dermatological Science

Volumn 14, Issue 3, 1997, Pages 217-224

  Zhou, Li Jun ^a   Inoue, Masayuki ^a   Gunji, Hironori ^a   Ono, Ichiro ^a   Kaneko, Fumio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Collagen; Collagenase; Interleukin 6; Interleukin 8; Prostaglandin E1; Scar derived fibroblasts; Transforming growth factor 1

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE TYPE 1; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E1; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; C PEPTIDE; COLLAGENASE; CYTOKINE; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HYPERTROPHIC SKIN DISEASE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; SKIN SCAR; ADOLESCENT; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR MATRIX; HYPERTROPHIC SCAR; METABOLISM; PATHOLOGY; SKIN;

ADOLESCENT; ADULT; ALPROSTADIL; C-PEPTIDE; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; COLLAGENASES; CYTOKINES; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; RECOMBINANT PROTEINS; SKIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031081960     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(96)00577-4     Document Type: Article

References (33)

1. [1] Grotendorst GR: Chemoattractants and growth factors. In The Wound Healing. Edited by IK Cohen, RF Diegelmann and WJ Lindblad. Saunders, Philadelphia, PA, 1992, pp. 237-246.
2. [2] Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F: Evaluation of cytokines in donor-site wound fluids. Scand J Plast Reconstr Surg Hand Surg 28: 269-273, 1994.
3. [3] Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F: Studies on cytokines related to wound healing in donor site wound fluid. J Dermatol Sci 10: 241-245, 1995.
4. [4] Aziz G, Ghahary A, Shen YJ, Scott PG, Gong Y, Tredget EE: Enhanced expression of mRNA for transforming growth factor-β, type I and type III procollagen in human post-burn hypertrophic scar tissues. J Lab Clin Med 122: 465-473, 1993.
5. 1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol 104: 750-754, 1995.
6. 1 - New Aspects on Pharmacology, Metabolism and Clinical Efficacy. Edited by C Diehm, H Sinzinger, W Rogatti. Springer. Berlin. 1991, pp. 1-5.
7. 1 esters and their inhibiting properties on rat blood platelet aggregation. Prostaglandins 15: 795-801, 1978.
8. 1 in severe peripheral vascular diseases. Lancet 1: 155-156, 1973.
9. 1 in severe vascular diseases. Lancet 2: 810, 1976.
10. 1 ointment on chronic skin ulcers and relation between tissue oxygen tension and its clinical efficacy. Skin Res (Japanese) 35(suppl): 210-218, 1993.
11. 1 ointment and lumbar sympathetic ganglion block on intractable skin ulcers accompanied by Burger's disease. Anesthesiology (Japanese) 41: 1000-1003, 1992.
12. 1 for the treatment of burned ulcers. Burns 22: 399-405, 1996.
13. 1 on human keratinocytes and dermal fibroblasts: A possible mechanism for the healing of skin ulcers. Exp Dermatol 3: 164-170, 1994.
14. 1: therapeutic potential for wound-healing. Arch Dermatol Res 287: 11-17, 1995.
15. [15] Hoopes JE, Su CT, Im MJ: Enzyme activities in hypertrophic scars. Plast Reconstr Surg 47: 132-137, 1971.
16. [16] Shetlar MR, Dobrokovsky M, Linares H: The hypertrophic scar; Glycoprotein and collagen components of burn scars. Proc Soc Exp Biol Med 138: 298-300, 1971.
17. [17] Diegelmann RF, Bryant CP, Cohen IK: Tissue alpha-globulins in keloid formation. Plast Reconstr Surg 59: 418-423, 1977.
18. 2 subtype. J Biol Chem 269: 11873-11877, 1994.
19. 2 Subtype. Prostaglandins 47: 151-168, 1994.
20. 3 subtype from human erythroleukaemia cells. Biochem J 298: 263-267, 1994.
21. 1 subtype. J Biol Chem 268: 26767-26772, 1993.
22. [22] Gunji H, Zhou LJ, Tateshita T, Ono I, Kaneko F: Suppressive effect of Tranilast on scar formation: An experimental study. J Jpn Plast Reconstr Surg (Japanese) 15: 721-729, 1995.
23. [23] Phillips C, Wenstrup RJ: Biosynthetic and genetic disorders of collagen. In The Wound Healing. Edited by IK Cohen, RF Diegelmann, WJ Lindblad. Saunders, Philadelphia, PA. 1992, pp. 152-176.
24. [24] Kanayama N, Terao T: Relationship of serum levels of pro-type I collagen peptide, pro-type III collagen peptide and type IV 7S collagen with cervical maturation. Gynecol Obstet Invest 34: 24-26, 1992.
25. [25] Raghow R, Postlethwaite AK, Keski-Oja J, Moses HL, Kang AH: Transforming growth factor β increases steady state levels of type 1 procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 79: 1285-1288, 1987.
26. [26] Quadrons E, Ramsamooj MS, Wilson DE: Role of mucus and prostaglandins in the gastric mucosal protective actions of sucralfate against ethanol-induced injury in rats. J Med 83 (suppl 3B): 19-23, 1987.
27. [27] Burch RM, McMillan BA: Sucralfate induces proliferation of dermal fibroblasts and keratinocyes in culture and granulation tissue formation in full-thickness skin wounds. Agents Funct 34: 229-231, 1991.
28. 2 synthesis by human keratinocyte cultures. Biochim Biophys Acta 919: 71-78, 1987.
29. 2 production. J Biol Chem 264: 11554-11557, 1989.
30. [30] Maradny EI, Kanayama N, Halim A, Maehara K, Sumimoto K. Terao T: Regulatory effect of aminopeptidase inhibitor bestaun on the cervix during induction of ripening by interleukin-8. J Leukocyte Biol 57: 832-836, 1995.
31. [31] Ito A, Imada K, Sato T, Kubo T, Matsushima K, Mori Y: Suppression of interleukin 8 production by progesterone in rabbit uterine cervix. Biochem J 301: 183-186, 1994.
32. [32] Singh RK, Gutman M, Reich G, Mennashe BE: Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res 55: 3669-3674, 1995.
33. [33] Maradny EI, Kanayama N, Halim A, Maehara K, Sumimoto K, Terao T: Interleukin-8 induces cervical ripening in rabbits. Am J Obstet Gynecol 171: 77-83, 1994.